Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast Cancer
Grazia Arpino(University of Naples Federico II), Sabino De Placido, Claudette Falato(Karolinska Institutet), Antonio Giordano(University of Siena), Carmine De Angelis(Baylor College of Medicine), Mario Giuliano(Regione Campania)
Cited by 58
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605